2014 Form 10-K Financial Statement
#000114420415011270 Filed on February 23, 2015
Income Statement
| Concept | 2014 | 2013 Q4 | 2013 |
|---|---|---|---|
| Revenue | $55.97M | $10.53M | $30.08M |
| YoY Change | 86.06% | 435.18% | 47.67% |
| Cost Of Revenue | $11.47M | $2.910M | $9.974M |
| YoY Change | 15.03% | 8.8% | |
| Gross Profit | $44.50M | $7.620M | $20.11M |
| YoY Change | 121.29% | 79.47% | |
| Gross Profit Margin | 79.5% | 72.36% | 66.84% |
| Selling, General & Admin | $17.94M | $3.200M | $16.39M |
| YoY Change | 9.44% | -23.63% | 72.12% |
| % of Gross Profit | 40.31% | 41.99% | 81.5% |
| Research & Development | $2.678M | $520.0K | $1.712M |
| YoY Change | 56.43% | -79.32% | 47.84% |
| % of Gross Profit | 6.02% | 6.82% | 8.51% |
| Depreciation & Amortization | $3.878M | $440.0K | $1.110M |
| YoY Change | 249.37% | -8.33% | 95.77% |
| % of Gross Profit | 8.72% | 5.77% | 5.52% |
| Operating Expenses | $20.61M | $4.160M | $18.10M |
| YoY Change | 13.88% | 65.43% | 69.49% |
| Operating Profit | $20.01M | $3.460M | $898.0K |
| YoY Change | 2127.84% | -195.18% | -2238.1% |
| Interest Expense | -$787.0K | $0.00 | $467.0K |
| YoY Change | -268.52% | -64.81% | |
| % of Operating Profit | -3.93% | 0.0% | 52.0% |
| Other Income/Expense, Net | $160.0K | $30.00K | -$305.0K |
| YoY Change | -152.46% | 26.56% | |
| Pretax Income | $19.38M | $3.490M | $126.0K |
| YoY Change | 15280.16% | -84.31% | -107.83% |
| Income Tax | -$9.368M | $100.0K | $20.00K |
| % Of Pretax Income | -48.34% | 2.87% | 15.87% |
| Net Earnings | $28.75M | $3.430M | $301.0K |
| YoY Change | 9450.5% | -84.56% | -119.99% |
| Net Earnings / Revenue | 51.36% | 32.57% | 1.0% |
| Basic Earnings Per Share | $2.61 | -$0.92 | |
| Diluted Earnings Per Share | $2.59 | $359.2K | -$0.92 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 10.94M shares | 5.071K shares | |
| Diluted Shares Outstanding | 11.05M shares | 5.071K shares |
Balance Sheet
| Concept | 2014 | 2013 Q4 | 2013 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $169.0M | $11.10M | $11.10M |
| YoY Change | 1422.52% | ||
| Cash & Equivalents | $169.0M | $11.11M | $11.10M |
| Short-Term Investments | |||
| Other Short-Term Assets | $1.100M | $600.0K | $600.0K |
| YoY Change | 83.33% | 100.0% | 100.0% |
| Inventory | $7.500M | $3.518M | $3.500M |
| Prepaid Expenses | $580.0K | ||
| Receivables | $17.30M | $12.51M | $12.50M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $195.0M | $27.72M | $27.70M |
| YoY Change | 603.97% | 223.56% | 222.09% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $5.200M | $4.537M | $4.500M |
| YoY Change | 15.56% | -7.03% | -8.16% |
| Goodwill | $1.838M | ||
| YoY Change | |||
| Intangibles | $10.41M | ||
| YoY Change | 12145.88% | ||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $15.40M | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Total Long-Term Assets | $64.60M | $16.78M | $16.80M |
| YoY Change | 284.52% | 223.89% | 229.41% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $195.0M | $27.72M | $27.70M |
| Total Long-Term Assets | $64.60M | $16.78M | $16.80M |
| Total Assets | $259.6M | $44.50M | $44.50M |
| YoY Change | 483.37% | 223.68% | 224.82% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $2.700M | $1.429M | $1.400M |
| YoY Change | 92.86% | -28.34% | -30.0% |
| Accrued Expenses | $4.900M | $1.326M | $1.400M |
| YoY Change | 250.0% | 43.04% | 55.56% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $13.20M | $3.538M | $3.500M |
| YoY Change | 277.14% | -54.12% | -54.55% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $106.5M | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $106.5M | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $13.20M | $3.538M | $3.500M |
| Total Long-Term Liabilities | $106.5M | $0.00 | $0.00 |
| Total Liabilities | $119.8M | $3.538M | $3.500M |
| YoY Change | 3322.86% | -66.6% | -93.81% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$48.47M | ||
| YoY Change | 10.67% | ||
| Common Stock | $1.000K | ||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $68.00K | ||
| YoY Change | |||
| Treasury Stock Shares | 9.233K shares | ||
| Shareholders Equity | $139.8M | $40.96M | $41.00M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $259.6M | $44.50M | $44.50M |
| YoY Change | 483.37% | 223.68% | 224.82% |
Cashflow Statement
| Concept | 2014 | 2013 Q4 | 2013 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $28.75M | $3.430M | $301.0K |
| YoY Change | 9450.5% | -84.56% | -119.99% |
| Depreciation, Depletion And Amortization | $3.878M | $440.0K | $1.110M |
| YoY Change | 249.37% | -8.33% | 95.77% |
| Cash From Operating Activities | $22.03M | -$2.860M | -$5.484M |
| YoY Change | -501.77% | -113.01% | 3902.92% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $1.120M | -$30.00K | $191.0K |
| YoY Change | 486.39% | -112.5% | -34.59% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$34.63M | $2.260M | $20.46M |
| YoY Change | -269.26% | 22500.0% | |
| Cash From Investing Activities | -$35.75M | $2.230M | $20.27M |
| YoY Change | -276.39% | 792.0% | -7089.66% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $0.00 | $433.0K | |
| YoY Change | -100.0% | -113.28% | |
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | $171.7M | 810.0K | -$3.689M |
| YoY Change | -4753.1% | -126.64% | -938.41% |
| NET CHANGE | |||
| Cash From Operating Activities | $22.03M | -2.860M | -$5.484M |
| Cash From Investing Activities | -$35.75M | 2.230M | 20.27M |
| Cash From Financing Activities | $171.7M | 810.0K | -$3.689M |
| Net Change In Cash | $157.9M | 180.0K | -$9.173M |
| YoY Change | -1821.71% | -99.06% | -3127.39% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $22.03M | -$2.860M | -$5.484M |
| Capital Expenditures | $1.120M | -$30.00K | $191.0K |
| Free Cash Flow | $20.91M | -$2.830M | -$5.675M |
| YoY Change | -468.51% | -113.02% | 1222.84% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3538000 | USD |
| CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
13233000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | USD |
| CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
68000 | USD |
| CY2014Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
89501000 | USD |
| CY2014Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
159509000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-48472000 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-19725000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
40962000 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
139785000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
44500000 | USD |
| CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
263709000 | USD |
| CY2014 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Organization and Business</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">ANI Pharmaceuticals, Inc. and its consolidated subsidiary, ANIP Acquisition Company (together, “ANI,” the “Company,” “we,” “us,” or “our”) is a specialty pharmaceutical company, developing and marketing generic and branded prescription products. ANI was organized as a Delaware corporation in April 2001. At our two facilities located in Baudette, Minnesota, which have a combined manufacturing, packaging and laboratory capacity totaling 173,000 square feet, we manufacture oral solid dose products, as well as liquids and topicals, including those that must be manufactured in a fully contained environment due to their potency. We also perform contract manufacturing for other pharmaceutical companies.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">On June 19, 2013, BioSante Pharmaceuticals, Inc. (“BioSante”) acquired ANIP Acquisition Company (“ANIP”) in an all-stock, tax-free reorganization (the “Merger”) (Note 2), in which ANIP became a wholly-owned subsidiary of BioSante. BioSante was renamed ANI Pharmaceuticals, Inc. The Merger was accounted for as a reverse acquisition pursuant to which ANIP was considered the acquiring entity for accounting purposes. As such, ANIP's historical results of operations replace BioSante's historical results of operations for all periods prior to the Merger. The results of operations of both companies are included in our consolidated financial statements for all periods after completion of the Merger.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Our operations are subject to certain risks and uncertainties including, among others, current and potential competitors with greater resources, dependence on significant customers, lack of operating history and uncertainty of future profitability and possible fluctuations in financial results. The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates continuity of operations, realization of assets, and satisfaction of liabilities in the ordinary course of business. The propriety of using the going-concern basis is dependent upon, among other things, the achievement of future profitable operations, the ability to generate sufficient cash from operations, and potential other funding sources, including cash on hand, to meet our obligations as they become due. We believe the going-concern basis is appropriate for the accompanying consolidated financial statements based on our current operating plan through December 31, 2015.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, allowance for doubtful accounts, accruals for chargebacks, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, deferred taxes and valuation allowance, and the depreciable lives of long-lived assets. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
5104000 | USD |
| CY2014Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
8708000 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
9233 | shares |
| CY2014Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1666667 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1666667 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
7088000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
29795000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
18198000 | USD |
| CY2013Q2 | anip |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Restricted Cash
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
|
2260000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
|
10900000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
|
79000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Assets Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsNoncurrent
|
0 | USD |
| CY2013Q2 | us-gaap |
Goodwill
Goodwill
|
1838000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
|
33275000 | USD |
| CY2013Q2 | anip |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Severance
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedSeverance
|
2965000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
|
515000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
|
3480000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
|
29795000 | USD |
| CY2013 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
30228000 | USD |
| CY2013 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
89000 | USD |
| CY2013Q2 | us-gaap |
Share Price
SharePrice
|
1.22 | |
| CY2014Q4 | anip |
Business Combination Deferred Tax Assets Established Gross
BusinessCombinationDeferredTaxAssetsEstablishedGross
|
9600000 | USD |
| CY2014Q4 | anip |
Business Combination Deferred Tax Liabilities Established Gross
BusinessCombinationDeferredTaxLiabilitiesEstablishedGross
|
3900000 | USD |
| CY2014Q4 | anip |
Business Combination Deferred Tax Asset Liability Valuation Allowance Established
BusinessCombinationDeferredTaxAssetLiabilityValuationAllowanceEstablished
|
-5700000 | USD |
| CY2013 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
6200000 | USD |
| CY2014 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
0 | USD |
| CY2014Q4 | anip |
Business Combination Purchase Price Allocation Deferred Tax Assets Net
BusinessCombinationPurchasePriceAllocationDeferredTaxAssetsNet
|
0 | USD |
| CY2013Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
1480000 | USD |
| CY2014Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
5056000 | USD |
| CY2013Q4 | us-gaap |
Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
|
766000 | USD |
| CY2014Q4 | us-gaap |
Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
|
794000 | USD |
| CY2013Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
162000 | USD |
| CY2014Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
411000 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1152000 | USD |
| CY2014Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1368000 | USD |
| CY2013Q4 | us-gaap |
Inventory Gross
InventoryGross
|
3560000 | USD |
| CY2014Q4 | us-gaap |
Inventory Gross
InventoryGross
|
7629000 | USD |
| CY2013Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
42000 | USD |
| CY2014Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
111000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7734000 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9017000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3197000 | USD |
| CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3794000 | USD |
| CY2013 | us-gaap |
Revenues
Revenues
|
30082000 | USD |
| CY2014 | us-gaap |
Revenues
Revenues
|
55970000 | USD |
| CY2013 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
9974000 | USD |
| CY2014 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
11473000 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1712000 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2678000 | USD |
| CY2013 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
16388000 | USD |
| CY2014 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
17935000 | USD |
| CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1110000 | USD |
| CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3878000 | USD |
| CY2013 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
29184000 | USD |
| CY2014 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
35964000 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
898000 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
20006000 | USD |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4700000 | shares |
| CY2013 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.92 | |
| CY2014 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.59 | |
| CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5071000 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10941000 | shares |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
126000 | USD |
| CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5071000 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11053000 | shares |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
11060000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
45999000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
651000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
3932000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
4485000 | USD |
| CY2013 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-467000 | USD |
| CY2014 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-787000 | USD |
| CY2013 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-305000 | USD |
| CY2014 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
160000 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
19379000 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
20000 | USD |
| CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-9368000 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
106000 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
28747000 | USD |
| CY2013 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
4975000 | USD |
| CY2014 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
0 | USD |
| CY2013 | anip |
Net Income Loss Available To Common Stockholders Basic And Participating Securities
NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities
|
-4869000 | USD |
| CY2014 | anip |
Net Income Loss Available To Common Stockholders Basic And Participating Securities
NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities
|
28747000 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.96 | |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
2.61 | |
| CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.04 | |
| CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0 | |
| CY2013 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.92 | |
| CY2014 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.61 | |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.96 | |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
2.59 | |
| CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.04 | |
| CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0 | |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
4485000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
4485000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
4485000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
19642000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
42067000 | USD |
| CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
600000 | USD |
| CY2014 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3300000 | USD |
| CY2013 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
1800000 | USD |
| CY2013Q4 | anip |
Intangible Asset Purchase Agreement Quantity Acquired
IntangibleAssetPurchaseAgreementQuantityAcquired
|
31 | pure |
| CY2013Q4 | anip |
Intangible Asset Purchase Agreement Amount
IntangibleAssetPurchaseAgreementAmount
|
12500000 | USD |
| CY2014Q1 | anip |
Intangible Asset Purchase Agreement Payment
IntangibleAssetPurchaseAgreementPayment
|
8500000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3689000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
171653000 | USD |
| CY2014Q1 | anip |
Intangible Asset Purchase Agreement Payment
IntangibleAssetPurchaseAgreementPayment
|
4000000 | USD |
| CY2013Q4 | anip |
Intangible Asset Purchase Agreement Number Of Immediate Release Products
IntangibleAssetPurchaseAgreementNumberOfImmediateReleaseProducts
|
20 | pure |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
600000 | shares |
| CY2013Q3 | anip |
Options Previously Granted Approved By Shareholder
OptionsPreviouslyGrantedApprovedByShareholder
|
300000 | shares |
| CY2014Q4 | anip |
Options Previously Granted Approved By Shareholder
OptionsPreviouslyGrantedApprovedByShareholder
|
300000 | shares |
| CY2014Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
1600000 | shares |
| CY2014Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3300000 | USD |
| CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
36000 | USD |
| CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
70000 | USD |
| CY2013Q4 | anip |
Contingent Consideration Classified As Liability Fair Value Disclosure
ContingentConsiderationClassifiedAsLiabilityFairValueDisclosure
|
0 | USD |
| CY2014Q4 | anip |
Contingent Consideration Classified As Liability Fair Value Disclosure
ContingentConsiderationClassifiedAsLiabilityFairValueDisclosure
|
0 | USD |
| CY2014 | us-gaap |
Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
|
0.15 | pure |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
36000 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3423000 | USD |
| CY2013 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-217000 | USD |
| CY2014 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-559000 | USD |
| CY2013 | anip |
Non Cash Compensation Relating To Business Combination
NonCashCompensationRelatingToBusinessCombination
|
4418000 | USD |
| CY2014 | anip |
Non Cash Compensation Relating To Business Combination
NonCashCompensationRelatingToBusinessCombination
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
7081000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4784000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
708000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3468000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
188000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
558000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-565000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
225000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-67000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1651000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5289000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
22033000 | USD |
| CY2013 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-195000 | USD |
| CY2014 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
0 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5484000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
22033000 | USD |
| CY2013 | us-gaap |
Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
|
18198000 | USD |
| CY2014 | us-gaap |
Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
|
0 | USD |
| CY2013 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
0 | USD |
| CY2014 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
34634000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
191000 | USD |
| CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1120000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
20267000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-35754000 | USD |
| CY2013 | us-gaap |
Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
|
0 | USD |
| CY2014 | us-gaap |
Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
|
46680000 | USD |
| CY2013 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-4065000 | USD |
| CY2014 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
0 | USD |
| CY2013 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
433000 | USD |
| CY2014 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
| CY2013 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
| CY2014 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
819000 | USD |
| CY2013 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
809000 | USD |
| CY2014 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
750000 | USD |
| CY2013 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
0 | USD |
| CY2014 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
784000 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
11094000 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
157932000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11000 | USD |
| CY2013 | us-gaap |
Interest Paid
InterestPaid
|
250000 | USD |
| CY2014 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
| CY2013 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
| CY2014 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
147000 | USD |
| CY2013 | us-gaap |
Stock Issued1
StockIssued1
|
40034000 | USD |
| CY2014 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
| CY2013 | anip |
Cancellation Of Redeemable Convertible Preferred And Common Stock Value
CancellationOfRedeemableConvertiblePreferredAndCommonStockValue
|
53726000 | USD |
| CY2014 | anip |
Cancellation Of Redeemable Convertible Preferred And Common Stock Value
CancellationOfRedeemableConvertiblePreferredAndCommonStockValue
|
0 | USD |
| CY2013 | anip |
Acquired Non Cash Net Assets
AcquiredNonCashNetAssets
|
11597000 | USD |
| CY2014 | anip |
Acquired Non Cash Net Assets
AcquiredNonCashNetAssets
|
0 | USD |
| CY2013 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
4975000 | USD |
| CY2014 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
0 | USD |
| CY2014 | dei |
Document Type
DocumentType
|
10-K | |
| CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-12-31 | |
| CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
ANI PHARMACEUTICALS INC | |
| CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001023024 | |
| CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Accelerated Filer | |
| CY2014Q2 | dei |
Entity Public Float
EntityPublicFloat
|
263200000 | USD |
| CY2014 | dei |
Trading Symbol
TradingSymbol
|
ANIP | |
| CY2014 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Credit Concentration</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Our customers are primarily wholesale distributors, chain drug stores, group purchasing organizations, and other pharmaceutical companies.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the year ended December 31, 2014, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 27</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 17</font>% of net revenues, respectively. As of December 31, 2014, accounts receivable from these customers totaled <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 73</font>% of net accounts receivable. During the year ended December 31, 2013, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 27</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of net revenues, respectively.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
3538000 | USD |
| CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
123924000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
7796000 | USD |
| CY2013Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
20000 | USD |
| CY2014Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
4253000 | USD |
| CY2013Q4 | anip |
Accrued Medicaid Rebates
AccruedMedicaidRebates
|
253000 | USD |
| CY2014Q4 | anip |
Accrued Medicaid Rebates
AccruedMedicaidRebates
|
2264000 | USD |
| CY2013Q4 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
110691000 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
773000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
7643000 | USD |
| CY2013Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
3307000 | USD |
| CY2013 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
| CY2014 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
138243000 | USD |
| CY2014Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1348000 | USD |
| CY2013 | anip |
Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
|
-2854000 | USD |
| CY2014 | anip |
Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
|
575000 | USD |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2700000 | shares |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-42715000 | USD |
| CY2013 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
0 | USD |
| CY2014 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-14459000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-2260000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2013 | us-gaap |
Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
0 | USD |
| CY2014 | us-gaap |
Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
15623000 | USD |
| CY2013 | anip |
Increase Decrease Accrued Medicaid Rebates
IncreaseDecreaseAccruedMedicaidRebates
|
72000 | USD |
| CY2014 | anip |
Increase Decrease Accrued Medicaid Rebates
IncreaseDecreaseAccruedMedicaidRebates
|
2011000 | USD |
| CY2014Q4 | anip |
Fdic Guaranteed Amount
FdicGuaranteedAmount
|
250000 | USD |
| CY2014Q4 | anip |
Chargebacks And Other Accruals As Percent Of Gross Revenue
ChargebacksAndOtherAccrualsAsPercentOfGrossRevenue
|
0.5 | pure |
| CY2013 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
20000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
4233000 | USD |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0172 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.5500 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
0 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
21000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
120000 | shares |
| CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2014 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
43000 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
0 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
120000 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
458000 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
83000 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
452000 | shares |
| CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
635000 | USD |
| CY2013 | anip |
Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Business Combination
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInBusinessCombination
|
99000 | shares |
| CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
20000 | USD |
| CY2014 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
4818000 | USD |
| CY2013 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
20000 | USD |
| CY2014 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
5091000 | USD |
| CY2014 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
2113000 | USD |
| CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-221000 | USD |
| CY2014 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
154000 | USD |
| CY2013 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
414000 | USD |
| CY2014 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
2267000 | USD |
| CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
414000 | USD |
| CY2014 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
16726000 | USD |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
19.45 | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
6.36 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
31.59 | |
| CY2013 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
38000 | USD |
| CY2014 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
|
58000 | USD |
| CY2014 | us-gaap |
Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
|
-9368000 | USD |
| CY2013 | anip |
Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Business Combination Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice
|
59.59 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
50.35 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
14.44 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
14.35 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
14.44 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
4000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
60000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
6.36 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
73.96 | |
| CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P0Y | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P2Y4M24D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y8M12D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P8Y1M6D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y8M12D | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
638000 | USD |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
3755000 | USD |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-4869000 | USD |
| CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
28589000 | USD |
| CY2013 | anip |
Gain On Discontinued Operations Allocated To Common Shares Diluted
GainOnDiscontinuedOperationsAllocatedToCommonSharesDiluted
|
193000 | USD |
| CY2014 | anip |
Gain On Discontinued Operations Allocated To Common Shares Diluted
GainOnDiscontinuedOperationsAllocatedToCommonSharesDiluted
|
0 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
19211000 | USD |
| CY2014Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2500000 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
81000 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
19472000 | USD |
| CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
273000 | USD |
| CY2013 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
0 | USD |
| CY2014 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
4400000 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.350 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.350 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.010 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.010 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
2.459 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-3.004 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.865 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.346 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.012 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.161 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.484 | pure |
| CY2014 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y7M6D | |
| CY2014Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
|
1000000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
802000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
2149000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
16409000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
11798000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
418000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1292000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
17987000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
29023000 | USD |
| CY2013Q4 | anip |
Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
|
220000 | USD |
| CY2014Q4 | anip |
Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
|
587000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
526000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
467000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
374000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
496000 | USD |
| CY2013Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
1120000 | USD |
| CY2014Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
13442000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
16867000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
142000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
15439000 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
78000 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
53000 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
44000 | USD |
| CY2014 | anip |
Options Previously Granted Approved By Shareholders
OptionsPreviouslyGrantedApprovedByShareholders
|
325000 | shares |
| CY2014 | anip |
Options Previously Granted Approved By Shareholders Weighted Average Exercise Price
OptionsPreviouslyGrantedApprovedByShareholdersWeightedAverageExercisePrice
|
6.39 | |
| CY2013Q2 | anip |
Business Combination Cost Of Acquired Entity Purchase Price
BusinessCombinationCostOfAcquiredEntityPurchasePrice
|
29800000 | USD |
| CY2013 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
4975000 | USD |
| CY2013 | anip |
Adjustments To Additional Paid In Capital Non Cash Compensation Relating To Business Combination
AdjustmentsToAdditionalPaidInCapitalNonCashCompensationRelatingToBusinessCombination
|
4418000 | USD |
| CY2013 | anip |
Convertible Preferred Stock Cancelled
ConvertiblePreferredStockCancelled
|
53726000 | USD |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4869000 | USD |
| CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
28588000 | USD |
| CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
195000 | USD |
| CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
|
-0.007 | pure |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Hedging Transactions
DeferredTaxAssetsHedgingTransactions
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Hedging Transactions
DeferredTaxAssetsHedgingTransactions
|
12677000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
|
358000 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
29000 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
0 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
204000 | USD |
| CY2013 | anip |
Monitoring And Advisory Fee
MonitoringAndAdvisoryFee
|
500000 | USD |
| CY2013 | anip |
Monitoring And Advisory Fee In Conjunction With Business Combination
MonitoringAndAdvisoryFeeInConjunctionWithBusinessCombination
|
400000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
36000 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3423000 | USD |
| CY2013 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
433000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
809000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
750000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
29795000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
46680000 | USD |
| CY2014 | anip |
Embedded Derivative Bifurcated Amount Reclassified To Stockholders Equity Net Of Deferred Tax Asset Liability
EmbeddedDerivativeBifurcatedAmountReclassifiedToStockholdersEquityNetOfDeferredTaxAssetLiability
|
20195000 | USD |
| CY2014 | anip |
Net Adjustments To Additional Paid In Capital Bond Hedge Acquired Warrant Issued Net Of Deferred Tax Asset Liability
NetAdjustmentsToAdditionalPaidInCapitalBondHedgeAcquiredWarrantIssuedNetOfDeferredTaxAssetLiability
|
-2575000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
819000 | USD |
| CY2013Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
1800000 | USD |
| CY2014Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
1800000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
0 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
784000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
|
1107000 | USD |
| CY2013Q4 | anip |
Deferred Tax Liabilities Debt Discount
DeferredTaxLiabilitiesDebtDiscount
|
0 | USD |
| CY2014Q4 | anip |
Deferred Tax Liabilities Debt Discount
DeferredTaxLiabilitiesDebtDiscount
|
11892000 | USD |
| CY2014Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
143750000 | USD |
| CY2014Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
33059000 | USD |
| CY2013 | anip |
Gain On Discontinued Operations Allocated To Common Shares Basic
GainOnDiscontinuedOperationsAllocatedToCommonSharesBasic
|
194000 | USD |
| CY2014Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
110691000 | USD |
| CY2014 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
252000 | USD |
| CY2014 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
489000 | USD |
| CY2014 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
70000 | USD |
| CY2014 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
811000 | USD |
| CY2014 | anip |
Gain On Discontinued Operations Allocated To Common Shares Basic
GainOnDiscontinuedOperationsAllocatedToCommonSharesBasic
|
0 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.040 | pure |
| CY2014Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
32900000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
4485000 | USD |
| CY2014 | us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
approximately $11.2 million per year | |
| CY2014Q4 | us-gaap |
Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
|
0.030 | pure |
| CY2014 | anip |
Number Of Vendors
NumberOfVendors
|
3 | Vendors |
| CY2013Q4 | anip |
Class C Special Stock Value
ClassCSpecialStockValue
|
0 | USD |
| CY2014Q4 | anip |
Class C Special Stock Value
ClassCSpecialStockValue
|
0 | USD |
| CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
36000 | USD |
| CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3400000 | USD |
